Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis

A O Tzianabos1, D L Kasper, R L Cisneros

  • 1Channing Laboratory, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.

Insights

Polysaccharide A (PS A) from Bacteroides fragilis prevents abscess formation in a rat model. This immune molecule offers broad protection against various bacteria, suggesting clinical potential for intra-abdominal sepsis.

Area of Science:

  • Immunology
  • Microbiology
  • Sepsis Research

Background:

  • Intra-abdominal sepsis frequently leads to abscess formation, a significant cause of illness and death.
  • Bacteroides fragilis is a common bacterial isolate in these abscesses.
  • The capsular polysaccharide complex (CPC) of B. fragilis is known to promote abscess formation but can induce a protective T cell-dependent immune response when administered subcutaneously.

Purpose of the Study:

  • To investigate the protective role of polysaccharide A (PS A), a component of CPC, against abscess formation.
  • To determine if PS A can protect against challenge with bacteria commonly found in human intra-abdominal abscesses.
  • To evaluate the efficacy of PS A in a simulated fecal contamination model of intra-abdominal sepsis.

Main Methods:

  • Administered PS A to rats in a sepsis model.
  • Challenged animals with live heterologous bacterial species and B. fragilis.
  • Assessed protection against abscess formation induced by fecal contents inoculum.
  • Investigated the role of T cells in mediating protection.

Main Results:

  • PS A conferred protection against challenge with diverse bacterial species commonly found in human intra-abdominal abscesses.
  • Protection mediated by PS A was transferable via T cells.
  • PS A administration, even after bacterial challenge, effectively prevented abscess formation.
  • PS A demonstrated protective effects in a rat model simulating fecal contamination.

Conclusions:

  • Polysaccharide A exhibits broad protective activity against abscess formation induced by various bacteria.
  • PS A appears to suppress a non-specific host tissue reaction involved in abscess development.
  • PS A holds potential as a therapeutic agent for preventing abscesses in clinical settings of intra-abdominal sepsis.